Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2026

14 Oct 2026
Appointment of CEO and Executive Director
14 Sep 2026
Resignation of Managing Director and Appendix 3Z
4 Sep 2026
Change of Share Registry Details
27 Aug 2026
Appendix 4G
27 Aug 2026
Corporate Governance Statement
27 Aug 2026
Full Year Statutory Accounts and Appendix 4E
18 Aug 2026
Notice of change of interests of substantial holder
17 Aug 2026
HBV Treatment to Progress Towards Human Trials
21 Jul 2026
Quarterly Report 30 June 2026
13 Jul 2026
Sedarex First Milestone Met
13 Jul 2026
Application for quotation of securities
4 Jun 2026
R&D Tax Incentive
29 May 2026
Release From Voluntary Escrow
15 May 2026
Final Director’s Interest Notice
29 Apr 2026
Quarterly Report 31 March 2026
10 Apr 2026
Director Retirement
30 Mar 2026
Appointment of non-executive Director
19 Mar 2026
Investor update
18 Mar 2026
Hepatitis B Virus Program Update
6 Feb 2026
Retirement of Director
30 Jan 2026
Supplementary Prospectus
30 Jan 2026
Appendix 2A Application for quotation of securities
30 Jan 2026
Successful Issue of the Entitlement Offer Shortfall
29 Jan 2026
Quarterly Report 31 December 2025

2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 15 October 2026 Legal Notices and Privacy